当前位置: X-MOL 学术Comb. Chem. High Throughput Screen. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
T-cell Epitope-based Vaccine design for Nipah Virus by Reverse Vaccinology approach.
Combinatorial Chemistry & High Throughput Screening ( IF 1.8 ) Pub Date : 2020-08-31 , DOI: 10.2174/1386207323666200427114343
Praveen K P Krishnamoorthy 1 , Sekar Subasree 1 , Udhayachandran Arthi 1 , Mohammad Mobashir 2 , Chirag Gowda 3 , Prasanna D Revanasiddappa 3
Affiliation  

Aim and Objective: Nipah virus (NiV) is a zoonotic virus of the paramyxovirus family that sporadically breaks out from livestock and spreads in humans through breathing resulting in an indication of encephalitis syndrome. In the current study, T cell epitopes with the NiV W protein antigens were predicted.

Materials and Methods: Modelling of unavailable 3D structure of W protein followed by docking studies of respective Human MHC - class I and MHC - class II alleles predicted was carried out for the highest binding rates. In the computational analysis, epitopes were assessed for immunogenicity, conservation, and toxicity analysis. T – cell-based vaccine development against NiV was screened for eight epitopes of Indian - Asian origin.

Results: Two epitopes, SPVIAEHYY and LVNDGLNII, have been screened and selected for further docking study based on toxicity and conservancy analyses. These epitopes showed a significant score of -1.19 kcal/mol and 0.15 kcal/mol with HLA- B*35:03 and HLA- DRB1 * 07:03, respectively by using allele - Class I and Class II from AutoDock. These two peptides predicted by the reverse vaccinology approach are likely to induce immune response mediated by T – cells.

Conclusion: Simulation using GROMACS has revealed that LVNDGLNII epitope forms a more stable complex with HLA molecule and will be useful in developing the epitope-based Nipah virus vaccine.



中文翻译:

Nipah病毒的T细胞基于表位的疫苗设计,采用反向疫苗学方法。

目的和目的:Nipah病毒(NiV)是副粘病毒家族的一种人畜共患病毒,它偶尔从牲畜中爆发并通过呼吸在人类中传播,从而导致脑炎综合征。在当前的研究中,预测了具有NiV W蛋白抗原的T细胞表位。

材料和方法:对W蛋白不可用的3D结构进行建模,然后对预测的各自人类MHC-I类和MHC-II类等位基因进行对接研究,以获得最高的结合率。在计算分析中,评估了抗原决定簇的免疫原性,保守性和毒性分析。针对印度—亚洲血统的8个抗原决定簇,筛选了针对NiV的T细胞疫苗研制。

结果:根据毒性和保守性分析,筛选并选择了两个表位,SPVIAEHYY和LVNDGLNII,用于进一步的对接研究。通过使用等位基因-AutoDock的I类和II类,这些表位在HLA- B * 35:03和HLA-DRB1 * 07:03时分别显示出-1.19 kcal / mol和0.15 kcal / mol的显着评分。通过反向疫苗学方法预测的这两种肽很可能诱导T细胞介导的免疫反应。

结论:使用GROMACS进行的模拟显示LVNDGLNII表位与HLA分子形成了更稳定的复合物,将有助于开发基于表位的Nipah病毒疫苗。

更新日期:2020-11-02
down
wechat
bug